title: Cryptococcal meningitis in a patient treated with infliximab and mycophenolate mofetil for Behcet's disease.
authors.forename: Nicolas
authors.initials: N
authors.lastname: Kluger
authors.forename: Philippe
authors.initials: P
authors.lastname: Poirier
authors.forename: Philippe
authors.initials: P
authors.lastname: Guilpain
authors.forename: Marie-Thérèse
authors.initials: MT
authors.lastname: Baixench
authors.forename: Pascal
authors.initials: P
authors.lastname: Cohen
authors.forename: André
authors.initials: A
authors.lastname: Paugam
mesh_terms: D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D001528:Behcet Syndrome / Q000150:complications* / Q000188:drug therapy; D003455:Cryptococcus neoformans / Q000302:isolation & purification*; D006801:Humans; D000069285:Infliximab; D008297:Male; D016919:Meningitis, Cryptococcal / Q000209:etiology* / Q000382:microbiology; D008875:Middle Aged; D009173:Mycophenolic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000911:Antibodies, Monoclonal; D000069285:Infliximab; D009173:Mycophenolic Acid